The New Jersey courts have recently come under the spotlight as the Appellate Division decided to support plaintiffs’ requests to access Electronic Medical Records (EMRs) of healthcare providers and facilities, albeit under certain conditions. The decision is based on the case of Estate of Lasiw by Lasiw v. Periera, 475 N.J. Super. 378 (2023) amid growing demands from plaintiffs citing Rule 4:18-1, and Rule 4:10-2(a), (g), and (f).
Access to these EMRs has emerged as a point of contention in pre-trial discovery, as defendants have voiced concerns that granting plaintiffs unrestrained access could be overly taxing in terms of time and expense. They also worry that this might potentially lead to HIPAA violations concerning other patients.
This has unveiled a new layer of complexity around the intersection of legal proceedings and digital health data privacy. While the court’s decision is a stride towards greater transparency in legal disputes, it also raises essential questions around patient privacy and the implications of unbridled access to EMRs.
For lawyers serving healthcare providers, this is a significant development to keep in mind while navigating the complexities of data access requests in court cases. While this decision by the Appellate Division of the New Jersey courts leans towards plaintiffs, it underscores the importance of balancing demands for transparency, the rights of defendants, and data privacy concerns in a rapidly evolving digital health landscape.